CANONSBURG (dpa-AFX) - Momenta Pharmaceuticals, Inc. (MNTA) announced the FTC has granted early termination of the waiting period under the HSR Act in connection with the global collaboration agreement executed by the company with Mylan N.V.'s subsidiary, Mylan Ireland, to develop and commercialize six biosimilar candidates. The collaboration agreement with Mylan is effective as of February 9, 2016.
Under the collaboration, Mylan is obligated to pay Momenta a $45 million upfront cash payment within 30 days of the effective date.
Copyright RTT News/dpa-AFX